VIVIDION THERAPEUTICS
Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide drug and target discovery. Making accessible the broad set of proteins expressed in human cells, the company’s platform was spun out of the labs of Vividion’s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA. Vividion is committed to advancing and applying its pioneering synthetic and proteomic chemistry platforms to create therapeutics that will make a transformative difference in patients.
VIVIDION THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2013-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.vividion.com
Total Employee:
101+
Status:
Active
Contact:
(609)924-6452
Email Addresses:
[email protected]
Total Funding:
371.5 M USD
Technology used in webpage:
Domain Not Resolving IPv6 Google Google Cloud Microsoft Akamai Hosted
Similar Organizations
Aurinia Pharmaceuticals
Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Evvy
Evvy is for people with vaginas who want to be empowered with information about their microbiome.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
PresenceLearning
PresenceLearning makes live, online special education related services available to K-12 students.
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
XOMA
XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation
Current Advisors List
Current Employees Featured
Founder
Investors List
Woodline Partners
Woodline Partners investment in Series C - Vividion Therapeutics
Avoro Capital Advisors
Avoro Capital Advisors investment in Series C - Vividion Therapeutics
Logos Capital
Logos Capital investment in Series C - Vividion Therapeutics
SoftBank Vision Fund
SoftBank Vision Fund investment in Series C - Vividion Therapeutics
Boxer Capital
Boxer Capital investment in Series C - Vividion Therapeutics
Acuta Capital Partners
Acuta Capital Partners investment in Series C - Vividion Therapeutics
T. Rowe Price
T. Rowe Price investment in Series C - Vividion Therapeutics
Surveyor Capital
Surveyor Capital investment in Series C - Vividion Therapeutics
Nextech Invest
Nextech Invest investment in Series C - Vividion Therapeutics
Driehaus Capital Management
Driehaus Capital Management investment in Series C - Vividion Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-10-12 | Tavros Therapeutics | Vividion Therapeutics investment in Corporate Round - Tavros Therapeutics | 17.5 M USD |
Key Employee Changes
Official Site Inspections
http://www.vividion.com Semrush global rank: 660.5 K Semrush visits lastest month: 47.6 K
- Host name: 129.181.211.130.bc.googleusercontent.com
- IP address: 130.211.181.129
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Vividion Therapeutics"
Home — Vividion Therapeutics
Oct 8, 2024 · We combine the power of chemoproteomics and covalent chemistry to forge life-changing connections between precision therapeutics and previously undrugged drivers of …See details»
About Us - Vividion Therapeutics
Previously at Vividion, Dr. Patricelli was SVP, Early Discovery Sciences and led all early drug discovery efforts including target selection and validation, as well as the early development of …See details»
Covalent binding – Vividion | Bayer Global
Nov 7, 2023 · Vividion’s unique approach utilizes novel discovery technologies to unlock high value, previously unknown binding pockets in traditionally undruggable targets to generate first-in-class precision therapeutics in …See details»
Bayer strengthens drug discovery platform …
Berlin, Germany, August 5, 2021 - Bayer AG today announced the acquisition of Vividion Therapeutics, Inc. (Vividion), a US-headquartered biopharmaceutical company utilizing novel discovery technologies to unlock high value, …See details»
Join Us - Vividion Therapeutics
What truly sets Vividion apart is our team – we are a group inspired by the exciting science originating from our unique chemoproteomics platform, and driven by the prospect that our science can produce life-changing treatments.See details»
Vividion Therapeutics - Crunchbase Company …
Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses. Vividion Therapeutics announced the establishment of a new global research and development center.See details»
Bayer acquires small molecule startup Vividion …
Aug 5, 2021 · Bayer is beefing up its investment in new approaches for small molecule drug discovery with the acquisition of Vividion Therapeutics, an early-stage startup founded by Scripps Research chemists Benjamin F. Cravatt, …See details»
Bayer Strengthens Drug Discovery Platform …
Aug 5, 2021 · BERLIN-- ( BUSINESS WIRE )--Bayer AG today announced the acquisition of Vividion Therapeutics, Inc. (Vividion), a US-headquartered biopharmaceutical company utilizing novel discovery...See details»
Bayer Strengthens Drug Discovery Platform Through …
Aug 5, 2021 · BERLIN-- (BUSINESS WIRE)-- Bayer AG today announced the acquisition of Vividion Therapeutics, Inc. (Vividion), a US-headquartered biopharmaceutical company …See details»
Vividion Therapeutics to Expand with New Global …
Jul 25, 2024 · Vividion is a wholly owned and independently operating subsidiary of Bayer AG. The new facility will support the continued development of Vividion’s R&D capabilities, …See details»
Vividion Therapeutics to Expand with New Global …
Jul 23, 2024 · Vividion is a wholly owned and independently operating subsidiary of Bayer AG. The new facility will support the continued development of Vividion’s R&D capabilities, …See details»
Vividion Therapeutics to Expand with New Global …
Jul 23, 2024 · Vividion is a wholly owned and independently operating subsidiary of Bayer AG. The new facility will support the continued development of Vividion’s R&D capabilities, …See details»
Bayer Acquires Vividion Therapeutics for $ 2 Billion
Aug 9, 2021 · Berlin, Germany, August 5, 2021 – Bayer AG today announced the acquisition of Vividion Therapeutics, Inc. (Vividion), a US-headquartered biopharmaceutical company …See details»
Vividion Therapeutics - Contacts, Employees, Board …
Vividion Therapeutics has 8 current employee profiles, including Chief Development Officer (CDO), Immunology Shawn Rose. Vividion Therapeutics has 6 board members and advisors, …See details»
Aleksandra Rizo Appointed as CEO of Vividion …
Jan 24, 2023 · Since joining Vividion in 2022, Aleksandra Rizo has been the leader of the company’s Research and Development organization, helping to shape the portfolio and …See details»
Vividion Therapeutics Company Profile 2024: Valuation, …
Vividion Therapeutics is headquartered in San Diego, CA. What is the size of Vividion Therapeutics? Vividion Therapeutics has 200 total employees. What industry is Vividion …See details»
Vividion Therapeutics - Craft
Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide drug and target discovery.See details»
Vividion Therapeutics Recognized as a San Diego area …
SAN DIEGO – November 21, 2022 – Vividion Therapeutics, Inc., a biotechnology company utilizing novel discovery technologies and advanced science to find new solutions for …See details»
Vividion Announces $135 Million Series C Financing to …
Feb 24, 2021 · Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines …See details»
Vividion Appoints Patty Allen, Experienced Financial …
Jan 7, 2021 · Ms. Allen currently serves on multiple boards of directors for both private and public biotechnology companies. Earlier, she served in financial related roles of increasing …See details»